Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06192680
What this trial is testing

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Harbin Medical University 63
Testing effectiveness (Phase 2)Study completedNCT03278379
What this trial is testing

Avelumab in G2-3 NET

Who this might be right for
Neuroendocrine Tumors
Sunnybrook Health Sciences Centre 17
Large-scale testing (Phase 3)UnknownNCT00025688
What this trial is testing

Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Theradex
Not applicableUnknownNCT05233540
What this trial is testing

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

Who this might be right for
Anal CancerLocally Advanced Squamous Cell CarcinomaOligometastatic Disease+2 more
Aarhus University Hospital 60
Not applicableUnknownNCT02904850
What this trial is testing

Validation of a Kinetic Model of Erlotinib

Who this might be right for
Lung Cancer
University Hospital, Strasbourg, France 50
Testing effectiveness (Phase 2)Study completedNCT00300950
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Who this might be right for
Pancreas Cancer
GlobeImmune 176
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Not applicableNot Yet RecruitingNCT06604910
What this trial is testing

Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis

Who this might be right for
Muscle Loss
National Taiwan University Hospital 40
Post-approval studies (Phase 4)Study completedNCT01493713
What this trial is testing

Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerHepatic Metastasis
Grupo Espanol Multidisciplinario del Cancer Digestivo 83
Not applicableEnded earlyNCT00595296
What this trial is testing

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Who this might be right for
Breast Cancer
Janssen Diagnostics, LLC 461
Not applicableNot Yet RecruitingNCT06541171
What this trial is testing

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 220
Testing effectiveness (Phase 2)Looking for participantsNCT07110064
What this trial is testing

QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Advance Pancreatic Cancer
Du Juan 80
Not applicableUnknownNCT06405009
What this trial is testing

Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer

Who this might be right for
Gastric CancerOmental Metastasis
Northern Jiangsu People's Hospital 450
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387
What this trial is testing

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Active Not RecruitingNCT06193993
What this trial is testing

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more
National University Hospital, Singapore 10
Early research (Phase 1)Active Not RecruitingNCT05640193
What this trial is testing

LN-144 in People With Metastatic Melanoma to the Brain

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)WithdrawnNCT06161493
What this trial is testing

ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors

Who this might be right for
Ovarian CancerRecurrent Solid Tumors
Haider Mahdi
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Next Page